Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Kos

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Requirement for natural killer cells in the induction of cytotoxic T cellsF J Kos, E G Engleman
Immunology|October 10, 1998
Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YTF J Kos, H D Bear
Immunology Today|April 1, 1996
Immune regulation: a critical link between NK cells and CTLsF J Kos, E G Engleman
Medicinal Research Reviews|March 1, 1991
Apoptosis or programmed cell deathP Waring, F J Kos, A Müllbacher
Scandinavian Journal of Immunology|June 3, 1999
Alloreactive cytotoxic T-cell function, peptide nonspecificA Müllbacher, M Lobigs, F J Kos, et al.
The Journal of Experimental Medicine|December 1, 1994
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenesG Ikonomidis, Y Paterson, F J Kos, et al.
International Journal of Immunopharmacology|September 16, 2000
Protective role of IL-2 during activation of T cells with bryostatin 1F J Kos, D L Cornell, A B Lipke, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1995
Requirement for natural killer cells in the induction of cytotoxic T cellsF J Kos, E G Engleman
Immunology|October 10, 1998
Involvement of protein kinase C-delta in CD28-triggered cytotoxicity mediated by a human leukaemic cell line YTF J Kos, H D Bear
Immunology Today|April 1, 1996
Immune regulation: a critical link between NK cells and CTLsF J Kos, E G Engleman
Medicinal Research Reviews|March 1, 1991
Apoptosis or programmed cell deathP Waring, F J Kos, A Müllbacher
Scandinavian Journal of Immunology|June 3, 1999
Alloreactive cytotoxic T-cell function, peptide nonspecificA Müllbacher, M Lobigs, F J Kos, et al.
The Journal of Experimental Medicine|December 1, 1994
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenesG Ikonomidis, Y Paterson, F J Kos, et al.
International Journal of Immunopharmacology|September 16, 2000
Protective role of IL-2 during activation of T cells with bryostatin 1F J Kos, D L Cornell, A B Lipke, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Pageof 2